- Home
- AARD vs CPSS Comparison
AARD vs CPSS Comparison
Compare AARD & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- CPSS
- Stock Information
- Founded
- AARD 2017
- CPSS 1991
- Country
- AARD United States
- CPSS United States
- Employees
- AARD N/A
- CPSS N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- CPSS Finance: Consumer Services
- Sector
- AARD Health Care
- CPSS Finance
- Exchange
- AARD Nasdaq
- CPSS Nasdaq
- Market Cap
- AARD 216.6M
- CPSS 187.8M
- IPO Year
- AARD 2025
- CPSS 1992
- Fundamental
- Price
- AARD $7.74
- CPSS $8.79
- Analyst Decision
- AARD Strong Buy
- CPSS
- Analyst Count
- AARD 4
- CPSS 0
- Target Price
- AARD $31.50
- CPSS N/A
- AVG Volume (30 Days)
- AARD 113.5K
- CPSS 18.6K
- Earning Date
- AARD 01-01-0001
- CPSS 05-09-2025
- Dividend Yield
- AARD N/A
- CPSS N/A
- EPS Growth
- AARD N/A
- CPSS N/A
- EPS
- AARD N/A
- CPSS 0.79
- Revenue
- AARD N/A
- CPSS $185,463,000.00
- Revenue This Year
- AARD N/A
- CPSS $161.83
- Revenue Next Year
- AARD N/A
- CPSS $15.69
- P/E Ratio
- AARD N/A
- CPSS $11.43
- Revenue Growth
- AARD N/A
- CPSS N/A
- 52 Week Low
- AARD $7.74
- CPSS $7.03
- 52 Week High
- AARD $19.58
- CPSS $12.73
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- CPSS 40.74
- Support Level
- AARD N/A
- CPSS $8.49
- Resistance Level
- AARD N/A
- CPSS $9.04
- Average True Range (ATR)
- AARD 0.00
- CPSS 0.51
- MACD
- AARD 0.00
- CPSS 0.07
- Stochastic Oscillator
- AARD 0.00
- CPSS 45.00
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About CPSS Consumer Portfolio Services Inc.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.